(Q41333152)

29 September 2017

1 reference

title

Bioequivalence of controlled-release calcium antagonists (English)

1 reference

29 September 2017

Schall R

1

1 reference

29 September 2017

Müller FR

series ordinal

2

1 reference

29 September 2017

Müller FO

series ordinal

3

1 reference

29 September 2017

Luus HG

series ordinal

4

1 reference

29 September 2017

1 January 1997

1 reference

Clinical Pharmacokinetics

29 September 2017

1 reference

29 September 2017

32

1 reference

29 September 2017

1

1 reference

29 September 2017

75-89

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199732010-00004

29 September 2017

0 references

cites work

Stereoselective pharmacokinetics of dihydropyridine calcium antagonists

1 reference

12 December 2020

The risk of myocardial infarction associated with antihypertensive drug therapies

1 reference

12 December 2020

Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms

1 reference

12 December 2020

Presentation of results from bioequivalence studies

1 reference

12 December 2020

Comparison of absorption rates in bioequivalence studies of immediate release drug formulations

1 reference

12 December 2020

[Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists]

1 reference

12 December 2020

[The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state]

1 reference

12 December 2020

Effects of food on the bioequivalence of different verapamil sustained-release formulations.

1 reference

12 December 2020

Update on the statistical analysis of bioequivalence studies.

1 reference

12 December 2020

Pharmacokinetics of diltiazem after intravenous and oral administration

1 reference

12 December 2020

Bioequivalence of a slow-release and a non-retard formulation of isradipine.

1 reference

12 December 2020

Bioequivalence of racemic drugs

1 reference

12 December 2020

The relative bioavailability of two marketed controlled release diltiazem dosage forms at steady state in healthy volunteers

1 reference

12 December 2020

[Bioequivalence of generic drugs and substitution: example of depot verapamil]

1 reference

12 December 2020

Case-control study, meta-analysis, and bouillabaisse: putting the calcium antagonist scare into context

1 reference

12 December 2020

Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.

1 reference

12 December 2020

Stereochemistry and bioequivalence

1 reference

12 December 2020

Bioequivalence of two pharmaceutical forms of diltiazem

1 reference

12 December 2020

Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence

1 reference

12 December 2020

Bioequivalence of verapamil hydrochloride extended-release pellet-filled capsules when opened and sprinkled on food and when swallowed intact

1 reference

12 December 2020

Pharmacokinetic model of diltiazem.

1 reference

12 December 2020

Surgical bleeding: unexpected effect of a calcium antagonist

1 reference

12 December 2020

1 reference

12 December 2020

Relative bioavailability of four controlled-release nifedipine products

1 reference

12 December 2020

Pertinent correction to "Bioequivalence of generics and substitution: example Verapamil retard

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic effects of diltiazem

1 reference

12 December 2020

[Bioequivalence of nifedipine sustained-release formulations in comparison to standard preparations in solid state]

1 reference

12 December 2020

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

12 December 2020

Comparative pharmacokinetics and pharmacodynamics of two marketed bid formulations of diltiazem in healthy volunteers

1 reference

12 December 2020

A comparative review of the adverse effects of calcium antagonists

1 reference

12 December 2020

Calcium-channel antagonists for prevention of atherosclerosis

1 reference

12 December 2020

Comparative Pharmacokinetics and Bioavailability of Dilacor XR and Cardizem CD in Healthy Volunteers

1 reference

12 December 2020

Nifedipine and mortality. Grave defects in the dossier

1 reference

12 December 2020

Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.

1 reference

12 December 2020

Sensitivity in detecting drug-induced alterations in the PR interval: comparison of the surface electrocardiogram measured by a cardiologist versus routine automated computer analysis

1 reference

12 December 2020

10.2165/00003088-199732010-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

29 September 2017

0 references

1 reference